Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
Authors
Keywords
-
Journal
Journal of Hepatocellular Carcinoma
Volume Volume 8, Issue -, Pages 741-757
Publisher
Informa UK Limited
Online
2021-07-02
DOI
10.2147/jhc.s285726
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment
- (2021) Hui Jia et al. LIFE SCIENCES
- MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma
- (2020) Laura Gramantieri et al. CANCER RESEARCH
- RNA m 6 A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy
- (2020) Ziyou Lin et al. EMBO JOURNAL
- Role of the mTOR pathway in liver cancer: from molecular genetics to targeted therapies
- (2020) Xinjun Lu et al. HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma
- (2020) Dong Li et al. CANCER GENE THERAPY
- Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
- (2020) Loraine Kay D. Cabral et al. Cancers
- Valproic acid reverses Sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in HCC
- (2020) Xu Yang et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
- (2020) Zhongqiang Zhang et al. Cell Death & Disease
- Mechanisms of Notch signaling: a simple logic deployed in time and space
- (2019) Domingos Henrique et al. DEVELOPMENT
- PFKFB3/HIF-1α feedback loop modulates sorafenib resistance in hepatocellular carcinoma cells
- (2019) Qian Long et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma
- (2019) Ling Deng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy
- (2019) Jian-feng Zheng et al. MOLECULAR THERAPY
- miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
- (2019) Wen-Ping Xu et al. GUT
- The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
- (2019) Ling Wei et al. Molecular Cancer
- Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma
- (2019) Jacopo Gavini et al. Cell Death & Disease
- Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
- (2019) Lai Wei et al. Nature Communications
- MicroRNAs in Animal Models of HCC
- (2019) Francesca Fornari et al. Cancers
- LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
- (2019) Fengyuan Tang et al. Nature Communications
- COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment
- (2018) Xiao-Feng Dong et al. CLINICAL CANCER RESEARCH
- Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
- (2018) Man Tong et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
- (2018) Chun-Ming Wong et al. Nature Reviews Gastroenterology & Hepatology
- The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
- (2018) Daniela Pollutri et al. Cell Death & Disease
- Inhibition of Cyclin-dependent Kinase 5 - a Novel Strategy to Improve Sorafenib Response in HCC Therapy
- (2018) Maximilian A. Ardelt et al. HEPATOLOGY
- Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma
- (2018) Xuran Yang et al. Oncotarget
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1–Stat3
- (2017) Chuan Xing Wu et al. MOLECULAR CANCER THERAPEUTICS
- The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2
- (2017) Zhenhua Chen et al. Cell Death & Disease
- Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
- (2016) D. Koeberle et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice
- (2016) Andrea N. Edginton et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
- (2016) Yanmin Xu et al. CANCER LETTERS
- miR-181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF1 expression
- (2016) Junya Azumi et al. CANCER SCIENCE
- Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF
- (2016) Jiwen Cheng et al. Oncotarget
- An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells
- (2016) Shuyao Tang et al. Oncotarget
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
- (2015) Victoria Tovar et al. GUT
- The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling
- (2015) Guangchun Sun et al. Journal of Cancer
- Role of microRNA-30c Targeting ADAM19 in Colorectal Cancer
- (2015) Qian Zhang et al. PLoS One
- Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma
- (2015) Catia Giovannini et al. Oncotarget
- Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
- (2014) Dali Zhao et al. CELLULAR SIGNALLING
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alternative Mammalian Target of Rapamycin (mTOR) Signal Activation in Sorafenib-resistant Hepatocellular Carcinoma Cells Revealed by Array-based Pathway Profiling
- (2014) Mari Masuda et al. MOLECULAR & CELLULAR PROTEOMICS
- Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
- (2014) B. Zhai et al. MOLECULAR CANCER THERAPEUTICS
- In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
- (2014) Ramona Rudalska et al. NATURE MEDICINE
- Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma
- (2014) HAIYONG WANG et al. ONCOLOGY REPORTS
- Establishment and Characterization of 7 Novel Hepatocellular Carcinoma Cell Lines from Patient-Derived Tumor Xenografts
- (2014) Hong Xin et al. PLoS One
- Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
- (2013) Mitchell Cheung et al. CURRENT CANCER DRUG TARGETS
- Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma
- (2013) Yingjian Liang et al. HEPATOLOGY
- MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer
- (2013) Lionel Lim et al. HEPATOLOGY
- Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma
- (2013) Richard S. Finn et al. JOURNAL OF HEPATOLOGY
- Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells
- (2013) W-T Tai et al. Cell Death & Disease
- Sorafenib Inhibits Hypoxia-Inducible Factor-1 Synthesis: Implications for Antiangiogenic Activity in Hepatocellular Carcinoma
- (2012) L.-p. Liu et al. CLINICAL CANCER RESEARCH
- Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice
- (2012) Augusto Villanueva et al. GASTROENTEROLOGY
- PI3K regulation of the SKP-2/p27 axis through mTORC2
- (2012) K Shanmugasundaram et al. ONCOGENE
- Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
- (2011) Ying-Hong Shi et al. Autophagy
- PI3K-AKT-FoxO axis in cancer and aging
- (2011) Guri Tzivion et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs
- (2011) Florie Borel et al. HEPATOLOGY
- MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer
- (2011) Regalla Kumarswamy et al. INTERNATIONAL JOURNAL OF CANCER
- DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival
- (2011) John M. Luk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Everolimus Augments the Effects of Sorafenib in a Syngeneic Orthotopic Model of Hepatocellular Carcinoma
- (2011) A.-C. Piguet et al. MOLECULAR CANCER THERAPEUTICS
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
- (2010) J. Marin et al. CURRENT MEDICINAL CHEMISTRY
- The paradox of autophagy and its implication in cancer etiology and therapy
- (2009) Avital Eisenberg-Lerner et al. APOPTOSIS
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells
- (2009) Junfang Ji et al. HEPATOLOGY
- The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
- (2009) Ledu Zhou et al. MEDICAL ONCOLOGY
- Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma
- (2008) Z. Wang et al. CLINICAL CANCER RESEARCH
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search